255 related articles for article (PubMed ID: 16512835)
1. Human alpha2-globin nonsense-mediated mRNA decay induced by a novel alpha-thalassaemia frameshift mutation at codon 22.
Pereira FJ; do Céu Silva M; Picanço I; Seixas MT; Ferrão A; Faustino P; Romão L
Br J Haematol; 2006 Apr; 133(1):98-102. PubMed ID: 16512835
[TBL] [Abstract][Full Text] [Related]
2. A novel frameshift mutation (+G) at codons 15/16 in a beta0 thalassaemia gene results in a significant reduction of beta globin mRNA values.
Mo QH; Li XR; Li CF; He YL; Xu XM
J Clin Pathol; 2005 Sep; 58(9):923-6. PubMed ID: 16126871
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of beta-thalassaemia caused by 22-bp duplication.
Svasti S; Boonchoy C; Vanichsetakul P; Winichagoon P; Fucharoen S
Ann Hematol; 2008 Aug; 87(8):633-7. PubMed ID: 18392622
[TBL] [Abstract][Full Text] [Related]
4. In vitro characterization of the α-thalassemia point mutation HBA2:c.95+1G>A [IVS-I-1(G>A) (α2)].
Qadah T; Finlayson J; Ghassemifar R
Hemoglobin; 2012; 36(1):38-46. PubMed ID: 21967524
[TBL] [Abstract][Full Text] [Related]
5. Binary specification of nonsense codons by splicing and cytoplasmic translation.
Thermann R; Neu-Yilik G; Deters A; Frede U; Wehr K; Hagemeier C; Hentze MW; Kulozik AE
EMBO J; 1998 Jun; 17(12):3484-94. PubMed ID: 9628884
[TBL] [Abstract][Full Text] [Related]
6. α-thalassemia trait caused by frameshift mutations in exon 2 of the α2-globin gene: HBA2:c.131delT and HBA2:c.143delA.
Finlayson J; Ghassemifar R; Holmes P; Grey D; Newbound C; Pell N; Jennens M; Greenwood L; Beilby J
Hemoglobin; 2012; 36(5):511-5. PubMed ID: 22943743
[TBL] [Abstract][Full Text] [Related]
7. α(+)-Thalassemia trait caused by a frameshift mutation in exon 2 of the α2-globin gene [HBA2 c.244delT].
Waye JS; Walker L; Eng B
Hemoglobin; 2012; 36(2):205-7. PubMed ID: 22375514
[TBL] [Abstract][Full Text] [Related]
8. Frameshift mutation in the alpha2-globin gene causing alpha+ -thalassemia: codon 49 (-GC).
Eng B; Waye JS
Hemoglobin; 2008; 32(3):315-7. PubMed ID: 18473249
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular characterization of a new α-thalassemia mutation (HBA2:c.94A>C) generating an alternative splice site and a premature stop codon.
Qadah T; Finlayson J; Newbound C; Pell N; Pascoe M; Greenwood L; Holmes P; Grey D; Beilby J; Ghassemifar R
Hemoglobin; 2012; 36(3):244-52. PubMed ID: 22524210
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency.
Hurtado B; Muñoz X; Mulero MC; Navarro G; Domènech P; García de Frutos P; Pérez-Riba M; Sala N
Haematologica; 2008 Apr; 93(4):574-80. PubMed ID: 18322254
[TBL] [Abstract][Full Text] [Related]
11. Alpha+-thalassemia trait caused by a nonsense mutation in the alpha2-globin gene: codon 54 (CAG>TAG).
Eng B; Walker L; Waye JS
Hemoglobin; 2009; 33(1):72-4. PubMed ID: 19205977
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
13. Alpha-thalassemia phenotype induced by the new IVS-II-2 (T --> A) splice donor site mutation on the alpha2-globin gene.
Harteveld CL; Jebbink MC; van der Lely N; van Delft P; Akkermans N; Arkesteyn S; Giordano PC
Hemoglobin; 2006; 30(1):3-7. PubMed ID: 16540408
[TBL] [Abstract][Full Text] [Related]
14. A new Frameshift mutation on the α2-globin gene causing α⁺-thalassemia: codon 43 (TTC>-TC or TTC>T-C).
Joly P; Lacan P; Garcia C; Barro C; Francina A
Hemoglobin; 2012; 36(5):508-10. PubMed ID: 22738776
[TBL] [Abstract][Full Text] [Related]
15. Premature termination codons enhance mRNA decapping in human cells.
Couttet P; Grange T
Nucleic Acids Res; 2004; 32(2):488-94. PubMed ID: 14742663
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Nonsense Mediated Decay on Transcriptional Activity Within the Novel β-Thalassemia Mutation HBB: c.129delT.
Forster L; Ardakani RM; Qadah T; Finlayson J; Ghassemifar R
Hemoglobin; 2015; 39(5):334-9. PubMed ID: 26207313
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
18. Molecular spectrum of alpha-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects.
Harteveld CL; Yavarian M; Zorai A; Quakkelaar ED; van Delft P; Giordano PC
Am J Hematol; 2003 Oct; 74(2):99-103. PubMed ID: 14508795
[TBL] [Abstract][Full Text] [Related]
19. A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA.
Sako Y; Usuki F; Suga H
Nucleic Acids Symp Ser (Oxf); 2006; (50):239-40. PubMed ID: 17150906
[TBL] [Abstract][Full Text] [Related]
20. A novel frameshift mutation (+A) at codon 18 of the beta-globin gene associated with high persistence of fetal hemoglobin phenotype and deltabeta-thalassemia.
Feriotto G; Salvatori F; Finotti A; Breveglieri G; Venturi M; Zuccato C; Bianchi N; Borgatti M; Lampronti I; Mancini I; Massei F; Favre C; Gambari R
Acta Haematol; 2008; 119(1):28-37. PubMed ID: 18230963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
